Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi's Laboratories has informed that it enclosing the schedule of Earnings conference call - Q4 FY21 to be held on 29 May, 2021.
The above information is a part of company’s filings submitted to BSE.